Eton Pharmaceuticals Inc (ETON)
3.62
-0.03
(-0.82%)
USD |
NASDAQ |
May 17, 16:00
3.62
0.00 (0.00%)
After-Hours: 20:00
Eton Pharmaceuticals Enterprise Value: 81.36M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 81.36M |
| May 16, 2024 | 82.14M |
| May 15, 2024 | 82.14M |
| May 14, 2024 | 81.62M |
| May 13, 2024 | 79.57M |
| May 10, 2024 | 76.48M |
| May 09, 2024 | 76.61M |
| May 08, 2024 | 83.93M |
| May 07, 2024 | 83.93M |
| May 06, 2024 | 84.70M |
| May 03, 2024 | 83.68M |
| May 02, 2024 | 84.70M |
| May 01, 2024 | 82.90M |
| April 30, 2024 | 78.27M |
| April 29, 2024 | 78.79M |
| April 26, 2024 | 76.99M |
| April 25, 2024 | 68.51M |
| April 24, 2024 | 70.82M |
| April 23, 2024 | 72.62M |
| April 22, 2024 | 71.85M |
| April 19, 2024 | 70.31M |
| April 18, 2024 | 66.97M |
| April 17, 2024 | 69.03M |
| April 16, 2024 | 70.31M |
| April 15, 2024 | 71.08M |
| Date | Value |
|---|---|
| April 12, 2024 | 76.22M |
| April 11, 2024 | 76.74M |
| April 10, 2024 | 76.48M |
| April 09, 2024 | 80.08M |
| April 08, 2024 | 77.00M |
| April 05, 2024 | 80.59M |
| April 04, 2024 | 79.82M |
| April 03, 2024 | 80.85M |
| April 02, 2024 | 82.91M |
| April 01, 2024 | 84.70M |
| March 31, 2024 | 84.70M |
| March 28, 2024 | 80.32M |
| March 27, 2024 | 81.61M |
| March 26, 2024 | 81.86M |
| March 25, 2024 | 83.66M |
| March 22, 2024 | 85.72M |
| March 21, 2024 | 76.98M |
| March 20, 2024 | 73.90M |
| March 19, 2024 | 74.93M |
| March 18, 2024 | 73.39M |
| March 15, 2024 | 82.89M |
| March 14, 2024 | 98.56M |
| March 13, 2024 | 99.07M |
| March 12, 2024 | 97.02M |
| March 11, 2024 | 101.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
40.92M
Minimum
Sep 26 2022
230.58M
Maximum
Feb 17 2021
104.00M
Average
95.26M
Median
Enterprise Value Benchmarks
| Eli Lilly and Co | 755.52B |
| Evoke Pharma Inc | 4.203M |
| Outlook Therapeutics Inc | 178.78M |
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.811M |
| Revenue (Quarterly) | 7.966M |
| Total Expenses (Quarterly) | 8.766M |
| EPS Diluted (Quarterly) | -0.03 |
| Gross Profit Margin (Quarterly) | 62.85% |
| Profit Margin (Quarterly) | -10.18% |
| Earnings Yield | 1.10% |
| Operating Earnings Yield | 0.58% |
| Normalized Earnings Yield | 1.105 |